Zdrowie i gospodarka · 14/04/2020

FDA Announces Final Guidance for Stability Testing of New Veterinary Drugs in Climatic Zones III and IV

The US Food and Drug Administration (FDA) has released a final guidance document (GFI #259) for the stability testing of new veterinary drug substances and medicinal products in regions with climatic zones III and IV, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).